WHO approves Arthritis Drug for severe Covid-19 cases
The World Health Organization said on Friday that the arthritis therapy tocilizumab has been prequalified for use in patients hospitalised with severe Covid-19, in an effort to expand access to the costly medicine. The monoclonal antibody, which is used in ...
12 February, 2022
Read more